Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EEG Neurofeedback for Anxiety Disorder
NCT04562324Unknown
- Sponsor
- Tianjin Anding Hospital
- Start
- Sep 2019
- Primary completion
- Oct 2022
- Countries
- 1
01
Overview
Randomised, double-blind trial (4 arms), sponsored by Tianjin Anding Hospital. Primary endpoints: Hamilton Anxiety Rating Scale at 2 weeks and Generalized Anxiety Disorder-7 at 2 weeks. Status: unknown.
Beyond the preview
Go deeper on NCT04562324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04562324.